Key Role of Phosphoinositide 3-Kinase Class IB in Pancreatic Cancer
Authors:
- Federico SelvaggiFSFederico Selvaggi
- Richard BuusRBRichard Buus
- Tania MaffucciTMTania Maffucci
- Pierluigi Di SebastianoPSPierluigi Di Sebastiano
- Helmut FriessHFHelmut Friess
- Paolo InnocentiPIPaolo Innocenti
- Hemant M. KocherHemant M. Kocher
- Marco FalascaMarco Falasca
Open Access
- 14 October 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 16 (20) , 4928-4937
Abstract
Purpose: Phosphoinositide 3-kinase (PI3K) signaling is well established as important in cancer. To date most studies have been focused on the PI3K/p110 alpha isoform, which has been found to be mutated in several different cancers. The aim of our study was to determine which specific PI3K isoforms are involved in pancreatic ductal adenocarcinoma (PDAC) and investigate the effects of these isoforms on proliferation, survival, and induction of Akt activation in pancreatic cancer cells. Experimental Design: The expression of all PI3K isoforms and downstream targets was analyzed by immunohistochemistry in human pancreatic cancer tissue and normal counterparts. Isoform selective inhibitors and short interfering RNA (siRNA) were employed to investigate the effects of the different PI3Ks on proliferation, survival, and intracellular signaling in PDAC cell lines. Results: Immunohistochemical screening revealed high specific expression of the PI3K/p110 gamma isoform. Scoring indicated that 72% of the PDAC tissue stained positive for PI3K/p110 gamma, whereas no stain was detected in normal pancreatic ducts. Proliferation analyses after selective inhibition and siRNA downregulation of PI3K/p110 gamma showed that PI3K/p110 gamma, but not other PI3K isoforms, was required for cell proliferation. Overexpression of PI3K/p110 gamma indeed increased cell numbers and mediated activation of Akt in PDAC cell lines. Moreover, PI3K/p110 gamma was required for Akt activation via lysophosphatidic acid receptors. Conclusions: These data represent the first identification of a tumor-specific accumulation of the PI3K isoform p110 gamma in human cancer. Further, our results signify a critical role for PI3K/p110 gamma in pancreatic cancer, and we hypothesize that PI3K/p110 gamma overexpression is a key event in the disease progression. Clin Cancer Res; 16(20); 4928-37. (C) 2010 AACR.Keywords
This publication has 31 references indexed in Scilit:
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Class I PI3K in oncogenic cellular transformationOncogene, 2008
- Taming the PI3K team to hold inflammation and cancer at bayPharmacology & Therapeutics, 2008
- Evidence for functional redundancy of class IA PI3K isoforms in insulin signallingBiochemical Journal, 2007
- Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult MiceCancer Cell, 2007
- BCR-ABL Regulates Phosphatidylinositol 3-Kinase-p110γ Transcription and Activation and Is Required for Proliferation and Drug ResistanceJournal of Biological Chemistry, 2006
- Genetic Alterations and Aberrant Expression of Genes Related to the Phosphatidyl‐lnositol‐3′‐Kinase/Protein Kinase B (Akt) Signal Transduction Pathway in GlioblastomasBrain Pathology, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Amplification and overexpression of theAKT2 oncogene in a subset of human pancreatic ductal adenocarcinomasMolecular Carcinogenesis, 1998
- The activation of phosphatidylinositol 3-kinase by RasCurrent Biology, 1994